137 related articles for article (PubMed ID: 20016266)
1. Emerging role of FKBP51 in AKT kinase/protein kinase B signaling.
Pei H; Lou Z; Wang L
Cell Cycle; 2010 Jan; 9(1):6-7. PubMed ID: 20016266
[No Abstract] [Full Text] [Related]
2. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
3. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Pei H; Li L; Fridley BL; Jenkins GD; Kalari KR; Lingle W; Petersen G; Lou Z; Wang L
Cancer Cell; 2009 Sep; 16(3):259-66. PubMed ID: 19732725
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
5. A molecular link between AKT regulation and chemotherapeutic response.
Dibble CC; Manning BD
Cancer Cell; 2009 Sep; 16(3):178-80. PubMed ID: 19732717
[TBL] [Abstract][Full Text] [Related]
6. FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP.
Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S
Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840
[TBL] [Abstract][Full Text] [Related]
7. InterAKTions with FKBPs--mutational and pharmacological exploration.
Fabian AK; März A; Neimanis S; Biondi RM; Kozany C; Hausch F
PLoS One; 2013; 8(2):e57508. PubMed ID: 23469007
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats.
Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496
[TBL] [Abstract][Full Text] [Related]
9. The Many Faces of FKBP51.
Hähle A; Merz S; Meyners C; Hausch F
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669684
[TBL] [Abstract][Full Text] [Related]
10. FKBP51 regulates decidualization through Ser473 dephosphorylation of AKT.
Wei M; Gao Y; Lu B; Jiao Y; Liu X; Cui B; Hu S; Sun L; Mao S; Dong J; Yan L; Chen Z; Zhao Y
Reproduction; 2018 Mar; 155(3):283-295. PubMed ID: 29363568
[TBL] [Abstract][Full Text] [Related]
11. FK506-binding protein 51 is a possible novel tumoral marker.
Romano S; D'Angelillo A; Staibano S; Ilardi G; Romano MF
Cell Death Dis; 2010 Jul; 1(7):e55. PubMed ID: 21364660
[No Abstract] [Full Text] [Related]
12. Post-translational modifications and stress adaptation: the paradigm of FKBP51.
Rein T
Biochem Soc Trans; 2020 Apr; 48(2):441-449. PubMed ID: 32318709
[TBL] [Abstract][Full Text] [Related]
13. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
[TBL] [Abstract][Full Text] [Related]
14. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.
Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y
Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of large immunophilin FK506 binding protein 51 in cancer.
Romano S; Sorrentino A; Di Pace AL; Nappo G; Mercogliano C; Romano MF
Curr Med Chem; 2011; 18(35):5424-9. PubMed ID: 22087835
[TBL] [Abstract][Full Text] [Related]
16. The role of FKBP5 in cancer aetiology and chemoresistance.
Li L; Lou Z; Wang L
Br J Cancer; 2011 Jan; 104(1):19-23. PubMed ID: 21119664
[TBL] [Abstract][Full Text] [Related]
17. A perspective on AKT 25-plus years after its discovery.
Paraskevopoulou MD; Tsichlis PN
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676491
[TBL] [Abstract][Full Text] [Related]
18. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
[TBL] [Abstract][Full Text] [Related]
19. PI3K and AKT: Unfaithful Partners in Cancer.
Faes S; Dormond O
Int J Mol Sci; 2015 Sep; 16(9):21138-52. PubMed ID: 26404259
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between the CK2 and AKT signaling pathways in cancer.
Ruzzene M; Bertacchini J; Toker A; Marmiroli S
Adv Biol Regul; 2017 May; 64():1-8. PubMed ID: 28373060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]